Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-13-011118)

Filing Details

Accession Number:: 0001209191-13-011118
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-02-22 21:22:02
Reporting Period:: 2013-02-21

Filing Date:: 2013-02-22
Accepted Time:: 2013-02-22 21:22:02
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
353569	Quidel Corp	QDEL	In Vitro & In Vivo Diagnostic Substances (2835)	942573850

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1222788	John Tamerius	10165 Mckellar Court San Diego CA 92121	Svp - Clinical/Reg Affairs	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2012-02-21	1,100	$22.50	53,474	No	4	S	Direct
Common Stock	Disposition	2012-02-21	200	$21.41	53,274	No	4	S	Direct
Common Stock	Disposition	2012-02-22	24,700	$22.40	28,574	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The weighted average sale price for these transactions was $22.4034 per share, with a range of $22.30 to $22.55 per share. Upon request, the Reporting Person hereby understakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.